NNVC

NanoViricides (NNVC)

About NanoViricides (NNVC)

NanoViricides, Inc. is a clinical stage company, which engages in the development of nano-biopharmaceutical drugs against viruses. It focuses on anti-viral therapeutics through internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.

Details

Daily high

$1.28

Daily low

$1.23

Price at open

$1.24

52 Week High

$2.23

52 Week Low

$0.94

Market cap

22.1M

Dividend yield

0.00%

Volume

337,431

Avg. volume

342,085

P/E ratio

-2.42

NanoViricides News